FDA accepts applications for Circassia COPD products Duaklir, Tudorza

By Jaime De Leon | Aug 17, 2018 | 3:32 AM GMT

Circassia Pharmaceuticals plc (LSE:CIR) said FDA accepted for review an NDA for Duaklir Pressair aclidinium

Read the full 151 word article

How to gain access

Continue reading with a
two-week free trial.